CAS: 1256751-11-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Boceprevir-d9 REF: 4Z-B-533CAS: | - - - | To inquire | Mon 13 Jan 25 |
 | Boceprevir-d9 REF: TR-B674502CAS: 1256751-11-7 | - - - | 1,202.00 €~9,332.00 € | Tue 18 Feb 25 |
 | Boceprevir-d9 REF: 3D-GAC75111CAS: 1256751-11-7 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: 4Z-B-533
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Boceprevir-d9
Controlled ProductCAS:1256751-11-7
Applications A labelled NS3 serine protease inhibitor of hepatitis C virus. It is a COVID19-related …
Formula:
C27H9H36N5O5
Color and Shape:
Neat
Molecular weight:
528.73
Ref: TR-B674502
| 5mg | 9,332.00 € | ||
| 500µg | 1,202.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Boceprevir-d9
CAS:1256751-11-7
Boceprevir is a potent and selective inhibitor of the hepatitis C virus NS3/4A protease. Boceprevir …
Formula:
C27H45N5O5
Purity:
Min. 95%
Molecular weight:
528.7 g/mol
Ref: 3D-GAC75111
| 1mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
